TL;DR: Yemaachi Biotechnology is a Y Combinator Summer 2021 startup Diversifying precision cancer diagnostics and treatments, currently active with a team of 16.
Diversifying precision cancer diagnostics and treatments
Last verified:
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.
Built by LemStudio
Yes. Yemaachi Biotechnology was funded by Y Combinator in the Summer 2021 batch. Diversifying precision cancer diagnostics and treatments
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies…
Yemaachi Biotechnology was part of Y Combinator's Summer 2021 batch.
Yemaachi Biotechnology has a team of 16 people according to Y Combinator's directory.
Yemaachi Biotechnology is currently listed as Active with a team of 16 in Y Combinator's directory.
Loading interactive view…